未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Multicenter prospective EN-MARK study: efficacy of third-line trastuzumab deruxtecan and dynamic changes in biomarkers, including HER2 status多中心前瞻性EN-MARK研究:第三线曲妥珠单抗德鲁替康的疗效及HER2状态等生物标志物的动态变化
Ooki, A.; Osumi, H.; Shimada, K.; Machida, N.; Hara, H.; Takamatsu, M.; Ishizuka, N.; Fukuda, Y.; Hashimoto, W.; Yamaguchi, K.
分享
收藏
分享
收藏
分享
收藏
分享
收藏Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study) ( oct , 10.1007/s10120-024-01555-w , 2024)曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究) (10月,10.1007/s10120-024-01555-w,2024)
Kawakami, Hisato; Nakanishi, Koki; Makiyama, Akitaka; Konishi, Hirotaka; Morita, Satoshi; Narita, Yukiya; Sugimoto, Naotoshi; Minashi, Keiko; Imano, Motohiro; Inamoto, Rin; Kodera, Yasuhiro; Kume, Hiroki; Yamaguchi, Keita; Hashimoto, Wataru; Muro, Kei
分享
收藏
分享
收藏Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究)
Kawakami, Hisato; Nakanishi, Koki; Makiyama, Akitaka; Konishi, Hirotaka; Morita, Satoshi; Narita, Yukiya; Sugimoto, Naotoshi; Minashi, Keiko; Imano, Motohiro; Inamoto, Rin; Kodera, Yasuhiro; Kume, Hiroki; Yamaguchi, Keita; Hashimoto, Wataru; Muro, Kei
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏